Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05892068 | A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain | active not recruiting | Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02624973 | PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial(PETREMAC) | active not recruiting | Phase 2 | 200 | Haukeland University HospitalOTHER | 1 | Feb 12, 2026 |
| clinicaltrials |
| NCT05383196 | Onvansertib + Paclitaxel In TNBC | active not recruiting | Phase 1 / Phase 2 | 50 | Antonio Giordano, MDOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer(e3) | active not recruiting | Phase 3 | 1,939 | SWOG Cancer Research NetworkNETWORK | 2 | Feb 10, 2026 | clinicaltrials |
| NCT05501886 | Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)(VIKTORIA-1) | active not recruiting | Phase 3 | 701 | Celcuity IncINDUSTRY | 23 | Feb 10, 2026 | clinicaltrials |
| NCT05909397 | Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer(VERITAC-3) | active not recruiting | Phase 3 | 59 | PfizerINDUSTRY | 10 | Feb 10, 2026 | clinicaltrials |
| NCT04478279 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 / Phase 2 | 125 | Sapience TherapeuticsINDUSTRY | 2 | Feb 9, 2026 | clinicaltrials |
| NCT04639986 | Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC) | active not recruiting | Phase 3 | 331 | Gilead SciencesINDUSTRY | 3 | Feb 9, 2026 | clinicaltrials |
| NCT05239143 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 180 | Poseida Therapeutics, Inc.INDUSTRY | 1 | Feb 9, 2026 | clinicaltrials |
| NCT05333874 | CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage | active not recruiting | Early Phase 1 | 34 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT02747004 | A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer(Next MONARCH 1) | active not recruiting | Phase 2 | 234 | Eli Lilly and CompanyINDUSTRY | 14 | Feb 6, 2026 | clinicaltrials |
| NCT04909125 | Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation | active not recruiting | N/A | 132 | Royal North Shore HospitalOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06175390 | Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer(SKYLINE) | active not recruiting | Phase 2 | 81 | Institut CurieOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT00907868 | Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS)(BONBIS) | active not recruiting | N/A | 2,004 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT02763566 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer(MONARCH plus) | active not recruiting | Phase 3 | 463 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 5, 2026 | clinicaltrials |
| NCT05036096 | Cone Beam Breast CT for Breast Cancer Screening | active not recruiting | N/A | 1,024 | Koning CorporationINDUSTRY | 1 | Feb 5, 2026 | clinicaltrials |
| NCT01310530 | Partial Breast Proton Therapy for Early Stage Breast Cancer | active not recruiting | N/A | 150 | Loma Linda UniversityOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03424915 | Exercise, Fitness and Tumor Profiling in Breast Cancer Patients | active not recruiting | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03808662 | Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung | active not recruiting | Phase 2 | 107 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Feb 4, 2026 | clinicaltrials |
| NCT01468246 | The Young Women's Breast Cancer Study(HOHO) | active not recruiting | — | 1,302 | Dana-Farber Cancer InstituteOTHER | 2 | Feb 3, 2026 | clinicaltrials |
| NCT02246621 | A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer(MONARCH 3) | active not recruiting | Phase 3 | 493 | Eli Lilly and CompanyINDUSTRY | 22 | Feb 3, 2026 | clinicaltrials |
| NCT03070236 | PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions | active not recruiting | N/A | 912 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT04623554 | Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer(Neo-train) | active not recruiting | N/A | 102 | Zealand University HospitalOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT02297672 | Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant(PBSI) | active not recruiting | N/A | 75 | British Columbia Cancer AgencyOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT04454437 | Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments | active not recruiting | Phase 2 | 80 | Gilead SciencesINDUSTRY | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07068347 | Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors | active not recruiting | N/A | 60 | Superior UniversityOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT03615599 | Plant-based Diets and Risk of Cancer in the Adventist Health Study-2(AHS-2) | active not recruiting | — | 96,000 | Loma Linda UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT05130840 | Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer | active not recruiting | N/A | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT01984138 | REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy(REVIVE) | active not recruiting | Phase 2 | 33 | Polly A. Niravath, MDOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT01992432 | Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)(Brain fMRI-BC) | active not recruiting | — | 49 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT02432963 | Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy | active not recruiting | Phase 1 | 11 | City of Hope Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT03984695 | Sexual Health Empowerment for Women's Health(SHE-WOMEN) | active not recruiting | N/A | 279 | University of Kansas Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT06533670 | TME Alteration in HER2 Positive Breast Cancer | active not recruiting | — | 30 | Seoul National University HospitalOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07371910 | Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer | active not recruiting | Phase 3 | 200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05968144 | Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness(ADRIAN) | active not recruiting | Phase 1 / Phase 2 | 30 | University of Maryland, BaltimoreOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT02492607 | Management of Low-risk (Grade I and II) DCIS(LORD) | active not recruiting | N/A | 2,500 | The Netherlands Cancer InstituteOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT02779751 | A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer | active not recruiting | Phase 1 | 100 | Eli Lilly and CompanyINDUSTRY | 7 | Jan 26, 2026 | clinicaltrials |
| NCT03368729 | Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer | active not recruiting | Phase 1 / Phase 2 | 46 | University of Alabama at BirminghamOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT03878342 | Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast(ROMANCE) | active not recruiting | N/A | 295 | UNICANCEROTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05731791 | Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation(PPI) | active not recruiting | N/A | 17 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT04871516 | Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer | active not recruiting | N/A | 103 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT06519370 | FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer | active not recruiting | Phase 3 | 350 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03879577 | Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | active not recruiting | Phase 2 | 53 | University of ChicagoOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT03891953 | Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. | active not recruiting | Phase 1 | 98 | Novartis PharmaceuticalsINDUSTRY | 6 | Jan 21, 2026 | clinicaltrials |
| NCT04509648 | Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer(ARROW) | active not recruiting | N/A | 197 | Ruijin HospitalOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05327452 | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study | active not recruiting | N/A | 135 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05301114 | Social Risk Factors and Discrimination in Cancer Survivorship | active not recruiting | N/A | 1,116 | Medstar Health Research InstituteOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT04448886 | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC | active not recruiting | Phase 2 | 110 | Ana C Garrido-Castro, MDOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04320979 | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | active not recruiting | Phase 3 | 2,400 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT05826964 | Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer | active not recruiting | Phase 2 | 24 | University of MiamiOTHER | 1 | Jan 13, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Feb 13, 2026source: clinicaltrials